Toosendanin activates caspase-1 and induces maturation of IL-1β to inhibit type 2 porcine reproductive and respiratory syndrome virus replication via an IFI16-dependent pathway
Toosendanin (TSN)
0301 basic medicine
Veterinary sciences
Agricultural, veterinary and food sciences
Swine
Veterinary medicine
FOS: Veterinary sciences
Porcine Reproductive and Respiratory Syndrome
Virus Replication
Microbiology
Cell Line
03 medical and health sciences
SF600-1100
Macrophages, Alveolar
Animals
caspase-1; Interleukin-1β (IL-1β)
Porcine respiratory and reproductive syndrome virus
Swine Diseases
0303 health sciences
Porcine reproductive and respiratory syndrome virus (PRRSV)
Caspase 1
Triterpenes
3. Good health
FOS: Biological sciences
inhibitory activity
gamma-interferon-inducible protein 16 (IFI16)
Research Article
DOI:
10.1186/s13567-022-01077-2
Publication Date:
2022-07-29T10:04:33Z
AUTHORS (10)
ABSTRACT
Abstract Porcine reproductive and respiratory syndrome virus (PRRSV) is a prevalent endemic swine pathogen which causes significant economic losses in the global industry. Multiple vaccines have been developed to prevent PRRSV infection. However, they provide limited protection. Moreover, no effective therapeutic drugs are yet available. Therefore, there an urgent need develop novel antiviral strategies infection transmission. Here we report that Toosendanin (TSN), tetracyclic triterpene found bark or fruits of Melia toosendan Sieb. et Zucc., strongly suppressed type 2 replication vitro Marc-145 cells ex vivo primary porcine alveolar macrophages (PAMs) at sub-micromolar concentrations. The results transcriptomics revealed TSN up-regulated expression IFI16 cells. Furthermore, silencing enhanced anti-PRRSV activity was dampened by silencing, suggesting inhibition against IFI16-dependent. In addition, showed activated caspase-1 induced maturation IL-1β IFI16-dependent pathway. To verify role infection, analyzed effect exogenous rmIL-1β on replication, significantly inhibited PAMs dose-dependent manner. Altogether, our findings indicate inhibits very low concentrations (EC 50 : 0.16–0.20 μM) may opportunities for developing agents.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (65)
CITATIONS (9)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....